Brief: Geron Announces EMA Validation Of Marketing Authorization Application For Imetelstat For The Treatment Of Lower Risk Mds
29/09/2023 14:36
Sept 29 (Reuters) - Geron Corp GERN.O :
* GERON ANNOUNCES EMA VALIDATION OF MARKETING AUTHORIZATION
APPLICATION FOR IMETELSTAT FOR THE TREATMENT OF LOWER RISK MDS
* GERON CORP - REVIEW OF MAA IS EXPECTED TO BE ABOUT 14
MONTHS
Source text for Eikon: ID:nBwbSFC40a
Further company coverage: GERN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Geron
See all newsBrief: Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Geron Corporation reports results for the quarter ended June 30 - Earnings Summary
Geron's Q2 revenue rises on RYTELO growth
Brief: Geron Q2 EPS USD -0.02
Brief: Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)